School Access to Emergency Epinephrine Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
93pct
175d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (11)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2014 · fourth_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
Medical liability issues; H.R. 2094, H.R. 1733; continuing medical education; graduate medical education
Client expense: Not reported · Firm income: $30,000
2014 · third_quarter · Health Issues
Medical liability issues; H.R. 2094, H.R. 1733; continuing medical education; graduate medical education
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: Not reported · Firm income: $60,000
| Democratic |
| IL |
| David B. McKinley | Republican | WV |
| David Loebsack | Democratic | IA |
| Donna M. Christensen | Democratic | VI |
| Doris O. Matsui | Democratic | CA |
| Ed Whitfield | Republican | KY |
| G. K. Butterfield | Democratic | NC |
| Gene Green | Democratic | TX |
| Glenn Thompson | Republican | PA |
| Gus M. Bilirakis | Republican | FL |
| H. Morgan Griffith | Republican | VA |
| James P. McGovern | Democratic | MA |
| Janice D. Schakowsky | Democratic | IL |
| Jerry McNerney | Democratic | CA |
| John Barrow | Democratic | GA |
| John P. Sarbanes | Democratic | MD |
| Kathy Castor | Democratic | FL |
| Lois Capps | Democratic | CA |
| Lou Barletta | Republican | PA |
| Marsha Blackburn | Republican | TN |
| Matt Cartwright | Democratic | PA |
| Michael C. Burgess | Republican | TX |
| Michael F. Doyle | Democratic | PA |
| Michael T. McCaul | Republican | TX |
| Paul Tonko | Democratic | NY |
| Pete Sessions | Republican | TX |
| Peter T. King | Republican | NY |
| Peter Welch | Democratic | VT |
| Scott DesJarlais | Republican | TN |
| Steny H. Hoyer | Democratic | MD |
| Steve Scalise | Republican | LA |
| Tim Ryan | Democratic | OH |
| Tom Latham | Republican | IA |
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Medical liability issues; H.R. 2094, H.R. 1733; continuing medical education; graduate medical education
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Health Issues
Medical liability issues; H.R. 2094, H.R. 1733; continuing medical education; graduate medical education
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.1007 Asthma Management Plans in School Act; H.R. 1220 Asthma Inhalers Relief Act of 2013; H.R.275 End Radon in SchoolsH.R.1549 Helping Sick Americans Now Act; H.R.1578 To amend section 1101 of the Patient Protection and Affordable Care Act to provide additional funds to permit additional individuals to enroll under the preexisting condition insurance program and expand eligibility, to be funded through a temporary increase in the cigarette tax, and for other purposes; H.R.2094 School Access to Emergency Epinephrine Act; H.CON.RES.25 Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023; S.CON.RES.8 : An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023; S.10 Agriculture Reform, Food, and Jobs Act of 2013; S.954 Agriculture Reform, Food, and Jobs Act of 2013; HR 2216 Military Construction and Veterans Affairs, and Related Agencies Appropriations Act, 2014; H.R.2397 Department of Defense Appropriations Act, 2014; S.1429 Department of Defense Appropriations Act, 2014; H.R.2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014; S.1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014; S.1284 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014; H.R.2787 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014, S.1329 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014; H.R.2855 Department of State, Foreign Operations, and Related Programs Appropriations Act, Fiscal Year 2014, S.1372 Department of State, Foreign Operations, and Related Programs Appropriations Act, Fiscal Year 2014; H.R.2610 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2014; S.1243 Transportation, Housing and Urban Development, and Related Agencies Appropriations; H.R.2775 Continuing Appropriations Act, 2014; H.R.3547 Consolidated Appropriations Act, 2014; Issues related to the prevention of lung disease; Issues related to tobacco cessation; Issues related to the National Institutes of Health; Issues related to the implementation of the Affordable Care Act; Issues relating to chronic obstructive pulmonary disease; Issues related to tuberculosis; Issues related to lung cancer; Issues related health disparities and health equity; Issues related to influenza; Issues related to asthma; Issues related to smokefree air; Issues related to the implementation of the Presecription Drug User Fee Act; Issues related to the Family Asthma Act; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, U.S. Trade Representative (USTR), White House Office
2013 · fourth_quarter · Torts
Lobbying with regard to medical malpractice reform proposals generally, including issues relating to practice guidelines for providers and health courts.H.R. 1473/S. 1769 (Standard of Care Protection Act); to prevent certain Federal health care laws from establishing health care provider standards of care. S. 1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013); specific interest in the following Senate Finance Committee amendments: Carper-Enzi Amd. #5, filed but not offered, regarding GAO report to evaulaute reforms to reduce medical liability costs, to improve health care quality and to increase patient safety; and Toomey-Carper Amd. #1, to enact the "Standard of Care Protection Act" to prevent certain Federal health care laws from establishing health care provider standards of care. S.1685/H.R. 2957 (Behavioral Health Information Technology Act); to extend health information technology assistance eligibility to behavioral health, mental health, and substance abuse professionals and to limit the liability of such providers. H.R. 3717 (Helping Families in Mental Health Crisis Act); specific interest in provision enacting the "Behavioral Health Information Technology Act," to extend health information technology assistance eligibility to behavioral health, mental health and substance abuse professionals and to limit the liability of such providers; and in provision limiting liability of volunteer health care providers. H.R. 2094/S. 1503 (School Access to Emergency Epineprhine Act); specific interest in civil liability limitations for school employees/agents and prescribing physicians in relation to the administration of epinephrine. H.R. 332 (Equal Access to Justice for Victims of Gun Violence Act); to provide victims of gun violence access to the same civil remedies as are available to those injured through other means. General lobbying with regard to the liabltiy of rental car companies.
Client expense: $970,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions S. 972, Cutting Costly Codes Act of 2013, all provisions H.R. 2094, School Access to Emergency Epinephrine Act, all provisions H.R. 2835, Restoring Access to Medication Act of 2013, all provisionsS. 1647, Restoring Access to Medication Act, all provisions H.R. 3528, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2013, all provisions Repeal of Section 9003 of ACA - Prescription requirement for OTC drugs purchase ACA Section 2706 - Non-discrimination ACA implementation - exchanges, pending claims, transitions of care, 90-day grace period Electronic Health Records - Meaningful Use Regulations ICD-10 Repeal Sunshine Act Opioids Hypertension and Diabetes CMMI and Y Million Hearts Pharmacy Red Flags Preventative Services Surgeon General of the U.S. Public Health Service Over-the-counter access to oral contraceptives New York State SAFE Act/HIPAA concerns Drug Compounding Telehealth/Telemedicine Drug Diversion Prescriber education and mandatory/voluntary CME training Personalized medicine/molecular diagnostics Drug Shortages Mental Health
Client expense: $4,240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), President of the U.S., SENATE, U.S. Trade Representative (USTR), White House Office
2013 · fourth_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
Education and awareness of the 2013-2014 influenza season; education and awareness of pandemic and biodefense funding, including policy ramifications of recent BARDA contract awards; education and awareness of Dengue; general issues related to NIH funding; all provisions of HR 2094 "School Access to Emergency Epinephrine Act"; all provisions of HR2985 "The Combination Drug Development Incentive Act"; S1871 "Sustainable Growth Rate (SGR) Repeal and Medicare Beneficiary Access Improvement Act of2013"; and all provisions of HR1024 and S557 "Medication Therapy Management Empowerment Act of 2013"
Client expense: $790,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Client expense: $320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Client expense: $360,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
Section 5201 of the Affordable Care Act; in general. HR 1427 - Truth in Healthcare Marketing Act of 2013; in general. Comments re: Advancing Interoperability and Health Information Exchange. Issues relating to lithium button batteries; in general.Subsection 2706(a), Title XXVII, of the Public Health Service Act, the "Non-Discrimination in Health Care Providers" provision, in general. HR 2817 - Protect Patient Access to Quality Health Professionals Act of 2013; in general. HR 2094 - School Access to Emergency Epinephrine Act; in general.
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA)
2013 · fourth_quarter · Health Issues
Medical liability issues; H.R. 2094, H.R. 1733; continuing medical education; graduate medical education
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Health Issues
Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; FDA funding; NIH funding; general issues related to diabetes awareness; H.R.2094 and S.1503; general issues related to School Access to Emergency Epinephrine Act. S.1871 "Sustainable Growth Rate (SGR) Repeal and Medicare Beneficiary Access Improvement Act of 2013." H.R.1024 and S.557 "Medication Therapy Management Empowerment Act of 2013."
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Health Issues
Medical liability issues; H.R. 2094, H.R. 1733; continuing medical education; graduate medical education
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Education
AOTC draft bill, BUILD Career and Technical Education Act of 2013, CCDBG, Connect Ed, Democratic Leadership Meeting, STEMS Job Act, E-rate Hearing, ESEA, Fiscal Cliff, Education Funding, WIA, H.R.5, Student Success Act, H.R. 1526, H.R. 1652, H.R. 2549, H.R. 2878, H.R.2920 - Financial Literacy for Students Act, Healthy Forest Act, H.R.1911, H.R.2094, H.R.2637, H.R.2881, HR 3102, Funding cuts for SNAP, HR 527, Helium Reserve fund, Miller educator background check bill, Missing and Exploited Children Act, Perkins re-authorization, Pay It Forward Act, Early Childhood Education, Protecting Students from Concussions, Restoring Healthy Forests for Healthy Communities Act, S.1094, S.1356, S.457, Classified Employee of the Year, S.1238, S.1334, S. 1356, S. 649, student loan interest rate, teacher background checks
Client expense: $538,489 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2013 · third_quarter · Health Issues
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.1007 Asthma Management Plans in School Act; H.R. 1220 Asthma Inhalers Relief Act of 2013; H.R.275 End Radon in SchoolsH.R.1549 Helping Sick Americans Now Act; H.R.1578 To amend section 1101 of the Patient Protection and Affordable Care Act to provide additional funds to permit additional individuals to enroll under the preexisting condition insurance program and expand eligibility, to be funded through a temporary increase in the cigarette tax, and for other purposes; H.R.2094 Latest Title: School Access to Emergency Epinephrine Act; H.CON.RES.25 Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023; S.CON.RES.8 : An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023; S.10 Agriculture Reform, Food, and Jobs Act of 2013; S.954 Agriculture Reform, Food, and Jobs Act of 2013; HR 2216 Military Construction and Veterans Affairs, and Related Agencies Appropriations Act, 2014; H.R.2397 Department of Defense Appropriations Act, 2014; S.1429 Department of Defense Appropriations Act, 2014; H.R.2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014; S.1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014; S.1284 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014; H.R.2787 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014, S.1329 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2014; H.R.2855 Department of State, Foreign Operations, and Related Programs Appropriations Act, Fiscal Year 2014, S.1372 Department of State, Foreign Operations, and Related Programs Appropriations Act, Fiscal Year 2014; H.R.2610 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2014; S.1243 Transportation, Housing and Urban Development, and Related Agencies Appropriations; Issues related to the prevention of lung disease; Issues related to tobacco cessation; Issues related to the National Institutes of Health; Issues related to the implementation of the Affordable Care Act; Issues relating to chronic obstructive pulmonary disease; Issues related to tuberculosis; Issues related to lung cancer; Issues related health disparities and health equity; Issues related to influenza; Issues related to asthma; Issues related to smokefree air; Issues related to the implementation of the Presecription Drug User Fee Act; Issues related to the Family Asthma Act; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, U.S. Trade Representative (USTR), White House Office
2013 · third_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Education
AOTC draft bill, BUILD Career and Technical Education Act of 2013, CCDBG, Connect Ed, Democratic Leadership Meeting, STEMS Job Act, E-rate Hearing, ESEA, Fiscal Cliff, Education Funding, WIA, H.R.5, Student Success Act, H.R. 1526, H.R. 1652, H.R. 2549, H.R. 2878, H.R.2920 - Financial Literacy for Students Act, Healthy Forest Act, H.R.1911, H.R.2094, H.R.2637, H.R.2881, HR 3102, Funding cuts for SNAP, HR 527, Helium Reserve fund, Miller educator background check bill, Missing and Exploited Children Act, Perkins re-authorization, Pay It Forward Act, Early Childhood Education, Protecting Students from Concussions, Restoring Healthy Forests for Healthy Communities Act, S.1094, S.1356, S.457, Classified Employee of the Year, S.1238, S.1334, S. 1356, S. 649, student loan interest rate, teacher background checks
Client expense: Not reported · Firm income: $538,489
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2013 · third_quarter · Education
AOTC draft bill, BUILD Career and Technical Education Act of 2013, CCDBG, Connect Ed, Democratic Leadership Meeting, STEMS Job Act, E-rate Hearing, ESEA, Fiscal Cliff, Education Funding, WIA, H.R.5, Student Success Act, H.R. 1526, H.R. 1652, H.R. 2549, H.R. 2878, H.R.2920 - Financial Literacy for Students Act, Healthy Forest Act, H.R.1911, H.R.2094, H.R.2637, H.R.2881, HR 3102, Funding cuts for SNAP, HR 527, Helium Reserve fund, Miller educator background check bill, Missing and Exploited Children Act, Perkins re-authorization, Pay It Forward Act, Early Childhood Education, Protecting Students from Concussions, Restoring Healthy Forests for Healthy Communities Act, S.1094, S.1356, S.457, Classified Employee of the Year, S.1238, S.1334, S. 1356, S. 649, student loan interest rate, teacher background checks
Client expense: Not reported · Firm income: $538,489
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2013 · third_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Health Issues
H.R. 1701, Cutting Costly Codes Act of 2013, all provisions S. 972, Cutting Costly Codes Act of 2013, all provisions H.R. 2085, Diagnostic Innovation Testing and Knowledge Advancement Act of 2013, all provisions H.R. 2835, Restoring Access to Medication Act of 2013, all provisionsS. 1323, Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013, all provisions H.R. 3204, Drug Quality and Security Act, provisions relating to drug compounding S. 959, Pharmaceutical Quality, Security, and Accountability Act, all provisions H.R. 3089, Compounding Clarity Act of 2013, all provisions H.R. 2094, School Access to Emergency Epinephrine Act, all provisions H.R. 2073, Pulmonary Hypertension Research and Diagnosis Act of 2013, all provisions Affordable Care Act - repeal of Section 9003 - HSA/FSA OTC drugs prescription requirement Affordable Care Act Section 2607(a) - Provider Non-discrimination Genetic Information Nondiscrimination Act Personalized Medicine Electronic Health Records - Meaningful Use Regulations Health Information Technology In-office Ancillary Services Exception Prescription Drug Diversion and Abuse Regulation of laboratory developed tests Prescriber education and mandatory/voluntary CME training Pay-for-delay Physician Coding Rogue Online/Internet Pharmacies Telehealth/Telemedicine Prescription Drug Compounding Drug Shortages ICD-10 Repeal HIPAA Privacy/Security issues and accounting for disclosures Physician Compare Redesign Opioid Analgesics Shared Savings/Accountable Care Organization program Delivery Reform Health Insurance Reform Marketing of high stimulant/caffeine drinks to children Sunshine Act Supplemental Nutrition Assistance Program (SNAP)
Client expense: $4,270,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, White House Office
2013 · third_quarter · Health Issues
Section 5201 of the Affordable Care Act; in general. HR 1427 - Truth in Healthcare Marketing Act of 2013; in general. Comments re: Advancing Interoperability and Health Information Exchange. Issues relating to lithium button batteries; in general.Subsection 2706(a), Title XXVII, of the Public Health Service Act, the "Non-Discrimination in Health Care Providers" provision, in general. HR 2817 - Protect Patient Access to Quality Health Professionals Act of 2013; in general. HR 2094 - School Access to Emergency Epinephrine Act; in general.
Client expense: $130,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
2013 · third_quarter · Health Issues
Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; FDA funding; NIH funding; general issues related to diabetes awareness; H.R.2094 and S.1503; issues related to the Independent Payment Advisory Board; general issues related to School Access to Emergency Epinephrine Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Torts
Lobbying with regard to medical malpractice reform proposals generally, including issues relating to practice guidelines for providers and health courts.H.R. 2094/S. 1503 (School Access to Emergency Epinephrine Act) specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine. H.R. 332 (Equal Access to Justice for Victims of Gun Violence Act); to provide victims of gun violence access to the same civil remedies as are available to those injured through other means. General lobbying with regard to the liability of rental car companies. H.R. 1473 (Standard of Care Protection Act of 2013); to prevent certain Federal health care laws from establishing health care provider standards of care. H.R. 1733 (Good Samaritan Health Professionals Act of 2013); to limit the liability of health care professionals who volunteer to provide health care service in response to a disaster. (Safeguarding Access For Every Medicare Patient Act); draft legislation not formally introduced as of 9-30-13; to address electronic health records.
Client expense: $910,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2013 · third_quarter · Health Issues
User fee sequester/implementation issues related to PL 112-144; changes to the Affordable Care Act (PL 111-148)/Health Care & Education Reconciliation Act (PL 111-152), including Independent Payment Advisory Board; compounding of human/animal drugs (Pharmaceutical Compounding Quality and Accountability Act, S. 959); School Access to Emergency Epinephrine Act (H.R. 2094/ S. 1503)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Health Issues
Education and awareness of the 2013-2014 influenza season; education and awareness of pandemic and biodefense funding, including policy ramifications of recent BARDA contract awards; education and awareness of dengue; general issues related to FDA funding; general issues related to NIH funding; general issues related to diabetes awareness; all provisions of HR 2094 "School Access to Emergency Epinephrine Act"; and issues related to the continued over-the-counter availability of allergy, cough and coldmedicines that contain pseudoephedrine
Client expense: $1,310,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Client expense: $270,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
Medical liability issues; H.R. 2094, H.R. 1733; continuing medical education.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Health Issues
User fee sequester/implementation issues related to PL 112-144; changes to the Affordable Care Act (PL 111-148)/Health Care & Education Reconciliation Act (PL 111-152), including Independent Payment Advisory Board; compounding of human/animal drugs (Pharmaceutical Compounding Quality & Accountability Act, S. 959); "track and trace" (H.R. 1919, Safeguarding America's Pharmaceuticals Act); Animal Drug User Fee Amendments (PL 113-14); School Access to Emergency Epinephrine Act (HR 2094)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Torts
Lobbying with regard to medical malpractice reform proposals generally, including issues relating to health courts and practice guidelines for providers.H.R. 2094 (School Access to Emergency Epinephrine Act) specific interest in civil liability limitations for school employees and agents and prescribing physicians in relation to the administration of epinephrine H.R. 332 (Equal Access to Justice for Victims of Gun Violence Act); to provide victims of gun violence access to the same civil remedies as are available to those injured through other means. General lobbying with regard to the liability of rental car companies. H.R. 1473 (Standard of Care Protection Act of 2013); to prevent certain Federal health care laws from establishing health care provider standards of care. H.R. 1733 (Good Samaritan Health Professionals Act of 2013); to limit the liability of health care professionals who volunteer to provide health care service in response to a disaster. (Safeguarding Access For Every Medicare Patient Act); draft legislation not formally introduced as of 6-30-13; to address electronic health records.
Client expense: $950,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office